Showing posts with label chronic respiratory diseases. Show all posts
Showing posts with label chronic respiratory diseases. Show all posts

Tuesday, March 21, 2017

@RespiratoryBMC channel for Respiratory updates

Dear friends we are happy to present you new twitter channel @RespiratoryBMC!
@RespiratoryBMC on twitter will present OpenAccess research from the world known BioMedCentral’s Respiratory medicine journals!
https://twitter.com/RespiratoryBMC

The account will be covering content from all BioMedCentral’s Respiratory medicine journals Respiratory Research, Multidisciplinary Respiratory Medicine, Pneumonia, Asthma Research and Practice and COPD Research and Practice.  
FOLLOW @RespiratoryBMC!!!

Sunday, February 21, 2016

Link between LUNG and inflammatory bowel diseases and chronic liver diseases

Dear Respiratory Friends we are happy to present you new article on hot topic Lung and  inflammatory bowel diseases and chronic liver diseases from ERJ 2016!
This review is devoted to the distinct associations of inflammatory bowel diseases (IBD) and chronic liver disorders with chronic airway diseases, namely chronic obstructive pulmonary disease and bronchial asthma, and other chronic respiratory disorders in the adult population. While there is strong evidence for the association of chronic airway diseases with IBD, the data are much weaker for the interplay between lung and liver multimorbidities. The association of IBD, encompassing Crohn's disease and ulcerative colitis, with pulmonary disorders is underlined by their heterogeneous respiratory manifestations and impact on chronic airway diseases. 
http://erj.ersjournals.com/content/47/2/638
The potential relationship between the two most prevalent liver-induced pulmonary vascular entities, i.e. portopulmonary hypertension and hepatopulmonary syndrome, and also between liver disease and other chronic respiratory diseases is also approached. Abnormal lung function tests in liver diseases are described and the role of increased serum bilirubin levels on chronic respiratory problems are considered.
link to article:

Thursday, December 24, 2015

Merry Christmas to all Respiratory friends!!!

Thank you for all your permanent help and support in this hard year! We realized very useful things for promotion of ALL Respiratory conditions! We are hoping that we will continue this work with your help and in 2016!
 

Saturday, January 17, 2015

New E-approach to asthma: Automated Device for Asthma Monitoring and Management

ADAMM (Automated Device for Asthma Monitoring and Management) devices from Health Care Originals Inc. are displayed at the 2015 International CES at the Sands Expo and Convention Center on January 6, 2015 in Las Vegas, Nevada. The ADAMM is a wearable technology that automates asthma management and provides complete information for physicians.
http://healthcareoriginals.com/

By measuring vital signs and other biological readings, the ADAM will predict and log asthma attacks, and can recommend behavior changes as well. It's set to launch in the second quarter of this year, and the price has not yet been announced.
http://healthcareoriginals.com/

Wednesday, December 24, 2014

Merry Christmas to all Respiratory friends

Merry Christmas to all Respiratory friends!!!
Thank you for all your permanent help and support in this hard year! We realized very useful things for promotion of ALL Respiratory conditions! We are hoping that we will continue this work with your help and in 2015!
 

Sunday, November 30, 2014

Respi - new solution for COPD and Asthma

Respi is a startup aiming to enable patients with asthma, COPD and other respiratory conditions. Respi is an comprehensive management system, comprised of a mobile spirometer and software that offers personalized advice to enable disease optimization by patients and their physicians.

Smartphone Spirometer 

Mobile spirometer uses your smartphone’s sensors to ensure proper body posture during the measurement, and adjust the collected data based on environmental conditions such as pressure and temperature.

http://resp.io/

 

App

With Respi app you can visualize your spirometry data and easily understand your respiratory condition. In a single touch you can browse through your history (data) and understand your progress. You can see how medication increased your lung functionality, and track your asthma attacks using our localisation framework.

Wednesday, November 26, 2014

1st Eurasian Respiratory Summit 2014



I would like to share with you my experience and impressions about the 1st Eurasian Respiratory Summit, which took place in Istanbul, Turkey at 21-23 November 2014. The main topics of the Congress were:
Scientific Topics
• Recent Developments in Asthma
• Recent Developments in COPD
• Practical Applications in Pulmonary Diseases 1
• Pediatric pulmonary Diseases
• Developments in Lung Cancer Treatment
• Interstitial Pneumonopathy
• Recent Therapeutic Approaches in COPD
• Cochrane Compilation in Pulmonary Diseases
• Severe Asthma Diagnosis and Treatment
• Pleura Diseases
• Pulmonary Hypertension
• Occupational Pulmonary Diseases
• Practical Applications in Pulmonary Diseases 2
• Interventional Endobronchial Applications
• Smoking as a Global Health Concern
• Obstructive Sleep Apnea Syndrome
• Pneumonia
Interactive Round-table Meeting Topics
• Approaches to Serious Asthma Patient
• Challenges in COPD Treatment
• WH-Questions in Pneumonia
• Guide to Asthma-Rhinitis
• Allergen Spesific Immunotherapy

The conference was attended by a wide range of professionals (more than 200 persons) such as industry leaders, university academics and researchers from all the regions including Turkey, Middle East, Asia, North Africa and Europe. It was high level meeting, the speakers were world known leader in Respiratory medicine from 11 countries.

Finally we would like to thank the 1st Eurasian Respiratory Summit Scientific committee and its President Professor Bulent Tutluoglu, Turkey for a successful Conference and remarkable annual organization which allowed taking part in different discussions, to acquire useful information and to establish relations with international specialists.
My presentation from
https://www.researchgate.net/publication/268687304_COPD_in_Moldova

Sunday, August 3, 2014

AIRWAYS-ICPs - Integrated care pathways for airway diseases: new perspective

Dear Respiratory friends please read about new perspectives with AIRWAYS-ICPs project!
Chronic respiratory diseases are major non-communicable diseases. Asthma and allergic diseases occur throughout the life cycle and can begin during pregnancy and childhood. In Europe, they affect 30 million children and adults under 45 years of age. Chronic obstructive pulmonary disease (COPD) has an estimated annual death rate of over 4 million people globally. Among the European Union (EU) member states, asthma accounted for an average of 53 hospital admissions per 100 000 population in 2009, and the average COPD-related admission rate was 184. The annual direct and indirect costs in the 28 EU countries due to COPD or asthma are estimated at €48 billion and €34 billion, respectively. Chronic respiratory diseases affect active and healthy ageing. Asthma in children or adults is a common risk factor for COPD in adults. 

The aim of AIRWAYS-ICPs is to improve healthy life years and to reduce burden (emergency visits, avoidable hospitalisations, disability and costs) while improving quality of life worldwide, and, in the longer term, to reduce disease incidence by new and innovative prevention strategies.
AIRWAYS-ICPs has a clear strategic relevance with regard to the EU Health Strategy as it will bring added value to the existing public health knowledge:
  • To propose a common framework for chronic respiratory disease (and for comorbidities) ICPs for the entire EU which can then be expanded to other regions (e.g. the Commonwealth of Independent States) and which will allow comparability and trans-national initiatives.
  • To help risk stratification in chronic respiratory disease patients, using a common strategy.
  • To develop cost-effective policies, in particular strengthening those on smoking and environment exposure.
  • To have a significant implication on the health of citizens in the short term (reduction of morbidity, improvement of education in children and of work in adults) and in the long term (healthy ageing).
  • To propose a common simulation tool for the entire EU in order to assist physicians in the segmentation of patients and in the choice of pathways. 
    http://erj.ersjournals.com/content/44/2/304.extract?etoc

    More information was published last week in European Respiratory Journal: 
    J. Bousquet et al.
    Integrated care pathways for airway diseases (AIRWAYS-ICPs) Eur Respir J 2014 44:304-323; published ahead of print 2014, doi:10.1183/09031936.00014614
    http://erj.ersjournals.com/content/44/2/304.extract?etoc

Thursday, April 3, 2014

First EU summit on Chronic Diseases (3-4 April 2014)

Chronic diseases affect the sufferer over a long period of time and generally progress slowly. Some of them – cardiovascular diseases, cancer, chronic respiratory diseases, diabetes, mental illness – represent leading causes of mortality.
Tackling four major risk behaviours – smoking, alcohol abuse, unhealthy diet, sedentary lifestyle – can help prevent many chronic diseases. But to be effective, such efforts need to be based on targeted health promotion, prevention and early detection.
To efficiently address the challenge of chronic diseases, an integrated, horizontal approach is essential – involving all the relevant levels, from communities to policy makers.
Social and environmental determinants also play an important role in the development of chronic diseases, and there is a clear inequality in the burden of such conditions and in the access to prevention and control.

This first EU summit on chronic diseases will discuss medical, social and economic benefits of sustainable investments in health, ways to reduce the burden of chronic diseases, and how to strengthen the prevention and management of chronic diseases, with a focus on EU added value and action.
The first EU summit on chronic diseases brings together key policymakers, stakeholders and interest groups to explore ways to address chronic diseases effectively in the EU and to develop recommendations along the following questions:
  1. How does the expanding burden of chronic diseases affect the quality of life of citizens, the competitiveness of economies and the cohesion of societies and what can the EU do about it?
  2. How can the pressure of the expanding burden of chronic diseases on health systems be reduced and how can available resources be invested in the most efficient way?
  3. Which prevention measures are the most cost-effective in the short and in the long term, and how could they be implemented? How should the EU and its Member States promote their implementation? Which risk factors need to be addresses more efficiently?
  4. How do the health and care systems need to change to respond to the ageing challenge and growing phenomena of frailty and multi-morbidity?
  5. How to best reach, include and empower the most vulnerable and marginalised people successfully in prevention and care strategies?
  6. How could the European Union support Member States’ attempts towards containing the chronic disease burden? Which EU action would provide most added value – in economic, social and political terms?
http://ec.europa.eu/health/major_chronic_diseases/events/ev_20140403_en.htm
 
The summit will develop Conference conclusions and a set of policy recommendations for action clarifying on how the medical, social and economic burden of chronic diseases should be tackled in the European Union now and in the years to come

Wednesday, February 27, 2013

Awareness for Respiratory diseases: European level

European Respiratory Society produced documentary for increase awareness for Respiratory diseases.

Bridging the Health Divide in Europe: Reducing inequalities and the impact of austerity measures on respiratory healthcare

This European Respiratory Society Vision documentary was produced to help raise the awareness of inequality of healthcare across Europe, notably in respiratory medicine. Bringing together experts from different organizations such as the European Respiratory Society, World Health Organisation, EuroHealthNet, this video addresses important issues that are affecting respiratory healthcare in today's difficult economic climate.
The European Respiratory Society hosted a critical summit this summer to discuss the growing problem of health inequalities in Europe.
The key event, which brought together leading experts from politics and health, created an opportunity to implement change and address the issue of health inequalities, which are becoming even more apparent during tough economic times.
The aim of the summit, entitled ‘Bridging the Health Divide in Europe – exchanging experiences to reduce avoidable health inequalities and preventable respiratory diseases’, was to follow on from goals set out in the Tallinn charter. The event allowed healthcare stakeholders to exchange experiences on the best ways to deal with health inequalities.

Sunday, September 16, 2012

Take That TB: TB has many faces and many languages!

Dear friends, we are happy to present today to you our new partners international organization Take That TB! We had meeting at Vienna and discuss about this exiting project dedicated and created for patient with tuberculosis.


We are publishing very inspirational manifesto by Take That TB:

We are a group of former patients from Europe and Australia and we are trying to build a meeting area “From Patients For Patients”.
Our aim is the exchange between patients and the discussion about our experiences with TB.
We want to be a platform for patients on treatment and for former patients who want to exchange about their experiences with TB.
We want to be a chatroom for patients in isolation.
While others are busy working hard in the fight to develop better drugs and treatment regimes, we want to be a place for patients to get the support and understanding that only other patients can give…
Collectively we can offer great support to each other, and help raise the awareness of TB in our communities, and help remove the stigma this disease has unfortunately associated with it.
We welcome doctors and hospital staff to join us, to help you understand TB from another point of view… to help you have another resource to offer your patients to help them through their experience. 

We want to talk about our experiences during treatment and afterwards and make the stay in hospital a little bit better.
As a result of our exchange we want to make an ebook / book or journal with TB patient stories from as many countries as possible. We want to write this in our / your mother tongue (and English) to show that TB can be found worldwide and that TB has many faces and many languages!!
Not all patients have the possibility to use the Internet for information and many patients also have no computer.
So this document should also show these patients that TB has got not only THEM but many others, from all countries, all age groups and all social classes.
It could be support for the TB patients on treatment and a review for former patients.

Saturday, March 31, 2012

My story by Alpha One Antitrypsin Deficient sufferer

Today we are happy to publish real story of Alpha One patient from United Kingdom: Kay Anderson. Her story is very emotional and inspirational! Kay describes very beautiful effects of stop smoking. 
Thank you Kay for sharing you real story with us!
We are very grateful to Respiratory Decade Member from Brazil Doctor Marilia Varella for preparing of this post!



I was diagnosed with Alpha One Antitrypsin Deficiency (A1AD) at 45, a year before being diagnosed I got increasingly sick, I was always very slim but I dropped over 30lbs in weight and couldn't breathe on going up inclines or stairs and heavily polluted days, I lived in one of the most industrial city's in the UK at the time Manchester. I was initially to frightened to see the Doctor as I was so convinced I had 'lung cancer' finally I was urged off many friends and family to go find out.

I was seen by the Doctor locally and sent immediately for further tests to the Heart and Lung Specialist at a local Hospital, they ran a succession of tests and then finally asked could they perform a finger prick test to see if I had this incurable genetic condition (not known to me at the time), they assured me the risk was low as this disease was very rare, so not to worry. but needed to rule it out as I was too young to be showing signs of emphysema as this was my medical diagnoses at the current time.  I did the test and left.  One week later the phone call came through from the Hospital that I was a Alpha One Antitrypsin Deficient sufferer, and that I would immediately need to 'stop smoking' I was so relieved to not have lung cancer and really not know about this condition I put the phone down and carried on 'smoking' …big mistake.

Very few Doctors, Specialists and Nurses here in the UK know anything about my condition other than its a genetic one, here lys the problem had I been more informed and indeed explained to in depth I would have ceased smoking there and then! A lot happened and I moved down to Devon where the air is beautiful and pure and very clean, I was lucky and totally changed my life...however the 'smoking continued' and I grew sicker, I was put in touch with Adapt at Birmingham whom I thought would be able to help me, where I saw the Prof Stockley originally and then on further visits different Consultants, they explained the condition but still (perhaps through denial) I refused to listen ...I had been a smoker since the age of 15 and for me to quit was not something I wished to even consider life shortening or not! In 2009 I saw a gentleman Consultant at Adapt who gave me 2 years left to live and my Force Expiratory Volume (FEV) was that low at the time around 22% he wanted to list me there and then for 'transplant' ...however this was something he was not prepared to do as I was still smoking!! I was due to have a CT Scan done that day as at this point I had not had one, I decided after news on that scale to leave and come home to Devon and die!.....

My husband had tried all to stop me smoking and I was so increasingly out of breath I was shuffling along from the bedroom on my hands and knees to the lounge to sit and carry on lighting up (unbelievable) but true, I had never had children and asked that I may get a puppy Xmas 2009 my wish was granted and in came my bichon frise dog Reg, I had him 8 weeks and could just about manage to get down the steps and to the bottom of the avenue and back before I was ready to collapse with exhaustion and breathlessness, something now had to change! I was and needed to be responsible for my little dog whom I adored! Feb 2010 8 weeks after Xmas I quit! I saw hypnoses who I thought did nothing and I went on the electric cigs, which I still suck on to this day! I have been a non - smoker for just over 2 years I don't miss it and I know it has damaged me along with this disease where I will need a lung transplant someday soon, I will be 51 years old this June, however I fought back and walk both my dogs (I got another one ) as I love the breed so much I walk nearly a mile most days with them, my FEV on Dec 2011 was around 41% a huge increase!  People ask me who I achieved this well through hard work and dedication and strength of mind over health matters, I have always been a fighter and a survivor and I fought for my life (or what was left of it) against all odds! I am now on supplementary oxygen for my day to day activities as I de sat very quickly, however not as yet on 24/7 which I have been fortunate with on my diagnosis (however this will come) I am currently only 1 point away from that and clinging on by my finger nails!  .....so my daily regime is set in stone, I medicate, I relax , I pace myself and I walk , I eat healthy food, I drink very rarely and I avoid people and places as we have no protection  germs and infections are all extremely damaging to a Alpha One person and in some cases can be 'lethal' , we have no protection around our lungs so a cold can turn quickly to pneumonia, and of lungs eat themselves away as the neutrophil does not know when to stop eating the bad stuff and carries on eating the good (our lung tissue). This disease has completely ruined and devastated my life in every way you can think of I am like a 85year old women at just 50! I have very bad days and days where I am okay, I struggle with everything, getting dressed, washing myself, and my hair, and I am unable to do housework, or cook through lift and push actions...I have support from my husband who has been a godsend through this, and I am doing my best to hold on to my lung function through living like a women in a (bubble)! I have no life to speak of and I have no or little energy daily this never fluctuates! and as Alpha One is a progressive disease we get worse over time, there are treatments for us one being augmentation therapy ...however we are denied this in the UK this therapy enables the AAT to be replaced weekly by infusion  and helps keep us a healthy as is possible, it is by no means a cure, but can delay the need for transplant for many years in most cases, my only medications daily are those given to a COPD person who is of course a completely different fish to us in so many ways, and of course not really affected only through the damage incurred on the lungs they do make AAT which makes a huge difference! to them and their life expectancy..  however antitrypsin can and for no reason slip further so every 6 month assessment is critical for us, in order they can know when our time comes for listing for a 'transplant' we all require a double lung transplant, and this of course is terrifying!
Please be aware that if you smoke there are so many hidden and of course unknown diseases we carry or can have as a result of the destruction and devastation this can do to our bodies and health!, I know as I sit here writing this given the choice now of cancer or Alpha One I would have taken the C ...the reason is simple it is quick and without any further fear other than death...we are like 'walking corpses' who live and keep living with what we have until we are finally ready to be taken to the transplant room, the outcome of course of this is as individual as Alpha One some make it, some don't...Alpha One is a game of roulette and the dice can fall at any time, we live on a knife edge daily! this is no fun ride ...so think before you light up a cig....you may get lucky, you may not , you may die of cancer or you may find out like me you will become the walking dead for many years and suffer in silence where Alpha people go, with no cure, and no relief...please quit before you do the damage you will never repair or indeed heal. I am dying at just 50! learn from me. ......please!  The worse bit about all this is I was a fun and outgoing party person who lived to live, I moved in many circles as a young women and could have been a international model! I had more chances and lifestyles offered me than most and I have ended up like a old lady, chocking and fighting for breath! not such a pretty sight anymore. 
There are millions of related illnesses through cigarettes and maybe the Governments of all Countries could and should categorize them all...this might be a start! and save a lot of young people into the bargain...

Sunday, March 18, 2012

Cystic fibrosis gene therapy trial 2012

Government funding announced 16 March 2012 will allow a groundbreaking gene therapy trial for cystic fibrosis to go ahead. The £3.1million grant from the National Institute for Health Research (NIHR) and the Medical Research Council (MRC) will fund the largest trial of its type yet with 130 adults and children with cystic fibrosis taking part.
The trial, which is due to begin very soon, will be co-ordinated by the UK Cystic Fibrosis Gene Therapy Consortium (GTC), a group of scientists and clinical teams from Royal Brompton & Harefield NHS Foundation Trust, Imperial College London, the universities of Oxford and Edinburgh and NHS Lothian. The group has worked together for the last decade to develop gene therapy for
cystic fibrosis , which is the most common fatal inherited disease in the UK, affecting around 9,500 people nationally and over 90,000 worldwide.
The trial participants, of whom more than 50 per cent are patients at Royal Brompton Hospital, will receive the treatment by inhaling molecules of DNA wrapped in fat globules that deliver the replacement gene into the cells in the lung lining. Half the participants will receive the real treatment and half a placebo in a double-blind study. Patients aged 12 and over will receive one dose a month for one year.


Saturday, February 11, 2012

Respiratory Masterclass in COPD and Asthma, Dubai, 21-22 January 2012

Dear Respiratory friends,
I want to share with you my experience from Respiratory Masterclass in COPD and Asthma which took place in Dubai, 21-22 January 2012. The meeting was dedicated to the new COPD and Asthma guidelines, which were launched recently.
There were 2 days full of new knowledge and experience. Faculty team was conducted by Professor Paul Jones from St Georges University of London, UK - world-known leader in respiratory research. Everybody knows his questionnaire: Saint-George Respiratory Questionnaire (SGRQ) which became classical, was validated in many languages and new one COPD Assessment Test (CAT test), which became the part of new GOLD classification of COPD.

There were many brilliant presentations by world opinion leaders in Asthma and COPD. Professor David Manino from University of Kentucky College of Public Health Lexington, USA presented new statistical data about COPD: COPD: the big picture.

Professor Wisia Wedzicha from London, UK presented results of ECLIPSE Study.

Professor Neil Barnes from London, UK dedicated his presentation to the new treatment implications of the 2011 GOLD guideline.

Monday, January 2, 2012

New Anti-Smoking Campaign: Real life against Smoking

New Anti-smoking campaign was launched: the main idea of campaign is real life stories of the people who are suffering from loosing their relatives from non-communicable diseases which were caused by smoking. “One in Two” campaign is focusing on the fact that one in every two smokers will die from a tobacco-related disease. 

Schoolgirl Margaret O’Brien told her mothers story who died from lung cancer.

Here is a story of Pauline Bell from Wexford, whose husband George died at 48 from a heart attack.

Gerry Collins from Wicklow, who describes his experience with cancer.

Friday, December 2, 2011

Patients for patients: Your role in RESPIRATORY healthcare

Dear Respiratory Friends,
Today we are presenting new exiting RESPIRATORY Competition by Lovexair Foundation from Spain!!!
Its great opportunity for respiratory patients and doctors to enhance the role and impact of new ways and methods of education that will help to chronic respiratory patients from all over the world to be more active and healthy!




The prize: 500 Euros for the winning entry in this competition
How can you win?
Build an educational module for patients with chronic respiratory disease.

 “Patients for patients: Your role in respiratory healthcare” competition helps to share valuable ideas, knowledge and experience mainly from patients with chronic respiratory disease and healthcare specialists in order to create an advanced educational concept that can be used at global level, at low cost.
If you want to participate in this creative and educational programme that builds a permanent support system for patients using their feedback and win 500 Euros for your group or for your organisation:
Create your own educational module that includes content and methods on how best to teach patients or care-givers about managing their illness, their daily-life, or anything that improves their quality of life.

For further information, click here: in 
English or in Spanish

Good Respiratory Luck to everybody!!!